K Pharma,Inc. (TYO:4896)
Japan · Delayed Price · Currency is JPY 744.00
+2.00 (0.27%)
Jul 16, 2026, 9:22 AM JST
K Pharma,Inc. Market Cap
K Pharma,Inc. has a market cap or net worth of 8.62 billion as of July 15, 2026. Its market cap has decreased by -2.22% in one year.
Market Cap
8.62B
Enterprise Value
7.56B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
744.00
Market Cap Chart
Since October 17, 2023, K Pharma,Inc.'s market cap has decreased from 10.95B to 8.62B, a decrease of -21.22%. That is a compound annual growth rate of -8.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 8.62B | 12.60% |
| Dec 30, 2025 | 7.66B | 6.28% |
| Dec 30, 2024 | 7.21B | -13.75% |
| Dec 29, 2023 | 8.36B | -23.67% |
| Oct 17, 2023 | 10.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Immuno-Biological Laboratories | 9.21B |
| CellSeed | 8.81B |
| Nano Holdings | 8.65B |
| StemCell Institute | 7.84B |
| OncoTherapy Science | 7.67B |
| Kidswell Bio | 7.49B |
| ADR Biomedical Holdings | 7.15B |
| MEDINET | 7.00B |